A
ATRC icon

AlphaQuest’s AtriCure ATRC Stock Holding History

AlphaQuest’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,874
Closed -$351K – 189
2025
Q4 		$351K Buy
8,874
+7,861
+776% +$288K 0.02% 1094
2025
Q3 		$35.7K Sell
1,013
-12,732
-93% -$439K ﹤0.01% 2009
2025
Q2 		$450K Sell
13,745
-4,266
-24% -$139K 0.04% 652
2025
Q1 		$581K Buy
18,011
+12,949
+256% +$481K 0.06% 471
2024
Q4 		$155K Buy
5,062
+4,532
+855% +$146K 0.02% 958
2024
Q3 		$14.9K Sell
530
-5,338
-91% -$132K ﹤0.01% 1529
2024
Q2 		$134K Buy
5,868
+1,626
+38% +$37.5K 0.02% 863
2024
Q1 		$129K Buy
4,242
+1,348
+47% +$45.2K 0.02% 767
2023
Q4 		$103K Buy
+2,894
New +$108K 0.02% 761

Other funds holding ATRC

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AlphaQuest's ATRC Position: Q1 2026 in Review

AlphaQuest sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 8,874 shares — an estimated $351K sold.

AlphaQuest first reported a position in ATRC in Q4 2023 and held it in 9 quarters. The position peaked at $581K in Q1 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • AlphaQuest reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 8,874 AtriCure shares in Q1 2026, an estimated $351K.
  • AlphaQuest first reported a position in AtriCure in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's AtriCure position peaked at $581K in Q1 2025.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.